Jan-Paul Simard
CIK: 0002162361
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XBIT
XBiotech Inc.
Officer
Discretionary Trading P&L
Holdings
About Simard Jan-Paul
Simard Jan-Paul (SEC CIK 0002162361) files insider reports with the SEC as Co-Chief Executive Officer of XBiotech Inc. (XBIT).
Signal8 holds 2 ownership filings by Simard Jan-Paul (1 Form 3, 1 Form 4), filed on Oct 28, 2026. Those filings report 1 transaction, the latest on Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Simard Jan-Paul's filings is in AUSTIN.
Recent filings by Simard Jan-Paul
- Oct 26, 2026: Grant or award of XBIT derivative securities (Form 4, code A).
Other insiders filing for XBiotech Inc. (XBIT)
- SIMARD JOHN, Director
- Rademaker Craig Evan, Director
- Soffer David Spencer, Director
- Kuendig Thomas Martin, Director
- Troy Tevi David, Director